Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linagliptin in paediatric type 2 diabetes mellitus
NCT01342484Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 2011
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of linagliptin in type 2 diabetes mellitus (T2DM), sponsored by Boehringer Ingelheim. Started Apr 2011; status: completed.
02
Drugs
linagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01342484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01342484.